The Eclipse treatment planning system uses a single dosimetric leaf gap (DLG) value to retract all multileaf collimator leaf positions during dose calculation to model the rounded leaf ends. This study evaluates the dosimetric impact of the 2D variation of DLG on clinical treatment plans based on their degree of fluence modulation. In-house software was developed to retrospectively apply the 2D variation of DLG to 61 clinically treated VMAT plans, as well as to several test plans. The level of modulation of the VMAT cases were determined by calculating their modulation complexity score (MCS). Dose measurements were done using the MapCHECK device at a depth of 5.0 cm for plans with and without the 2D DLG correction. Measurements were compared against predicted dose planes from the TPS using absolute 3%/3 mm and 2%/2 mm gamma criteria for test plans and for VMAT cases, respectively. The gamma pass rate for the 2 mm, 4 mm, and 6 mm sweep test plans increased by 23.2%, 28.7%, and 26.0%, respectively, when the measurements were corrected with 2D variation of DLG. The clinical anal VMAT cases, which had very high MLC modulation, showed the most improvement. The majority of the improvement occurred for doses created by the 1.0 cm width leaves for both the test plans and the VMAT cases. The gamma pass rates for the highly modulated head and neck (H&N) cases, moderately modulated prostate and esophageal cases, and minimally modulated brain cases improved only slightly when corrected with 2D variation of DLG. This is because these cases did not employ the 1.0 cm width leaves for dose calculation and delivery. These data suggest that, at the very least, the TPS plans with highly modulated fluences created by the 1.0 cm fields require 2D DLG correction. Incorporating the 2D variation of DLG for the highly modulated clinical treatment plans improves their planar dose gamma pass rates, especially for fields employing the outer 1.0 cm width MLC leaves. This is because there are differences in DLG between the true DLG exhibited by the 1.0 cm width outer leaves and the constant DLG value modeled by the TPS for dose calculation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690211PMC
http://dx.doi.org/10.1120/jacmp.v17i1.5883DOI Listing

Publication Analysis

Top Keywords

variation dlg
20
test plans
16
vmat cases
16
dlg
12
dose calculation
12
gamma pass
12
highly modulated
12
plans
9
dosimetric leaf
8
leaf gap
8

Similar Publications

Article Synopsis
  • The KEAP1-NRF2 system activates antioxidant genes to combat oxidative stress, but mutations in this system can enhance cancer malignancy.
  • A study analyzed gene-panel data from over 60,000 solid tumor cases, revealing that mutations in NRF2 are common in esophageal and lung cancers and are linked to worse patient outcomes.
  • The research highlights that both NRF2 and KEAP1 genetic variations significantly impact cancer prognosis, therapy resistance, and the biological characteristics of different cancer types.
View Article and Find Full Text PDF
Article Synopsis
  • This study examines how variations in gantry and collimator angles affect dosimetric leaf gap (DLG) and leaf transmission factor (LTF) in a Varian LINAC with rounded-end multi-leaf collimators (MLCs).
  • The research involved various measurements using a TrueBeam LINAC and tested multiple angles and beam energies to assess dosimetric impacts through VMAT Picket Fence tests and patient-specific verification.
  • Findings revealed significant differences in DLG based on gantry angle, with the highest DLG at 270 degrees and the lowest at 90 degrees, suggesting a need for averaged DLG values for more accurate dose calculations, contrary to current Varian guidelines.
View Article and Find Full Text PDF

The study examined various properties of synthesized copolyesters PESC and PPSC. Inherent viscosities of the copolyesters, measured in 1,4-dioxane at 32 °C, were 0.65 dL/g for PESC and 0.

View Article and Find Full Text PDF

Rare X-linked variants carry predominantly male risk in autism, Tourette syndrome, and ADHD.

Nat Commun

December 2023

Department of Psychiatry and Behavioral Sciences, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, 94143, USA.

Article Synopsis
  • Autism spectrum disorder (ASD), Tourette syndrome (TS), and ADHD show a significant male bias, influenced by genetic and biological factors.
  • Researchers analyzed chromosome X for rare genetic variations using whole exome sequencing in ASD cases, focusing on maternal inheritance.
  • A new high-confidence risk gene for ASD (MAGEC3) was identified, and similar genetic variations contributing to vulnerability were found in males with TS and ADHD, enhancing understanding of the genetic basis of these disorders.
View Article and Find Full Text PDF

TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEAP1/NRF2 signaling.

J Exp Clin Cancer Res

August 2023

Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, China.

Background: Drug resistance limits the treatment effect of cisplatin-based chemotherapy in head and neck squamous cell carcinoma (HNSCC), and the underlying mechanism is not fully understood. The aim of this study was to explore the cause of cisplatin resistance in HNSCC.

Methods: We performed survival and gene set variation analyses based on HNSCC cohorts and identified the critical role of tumor necrosis factor alpha-induced protein 2 (TNFAIP2) in cisplatin-based chemotherapy resistance.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!